When it comes to complex biotech stocks like Recursion Pharmaceuticals (NASDAQ: RXRX), skilled investors are likely to have an outsized advantage in understanding how the future will play out. Whether it's a matter of how to judge developments like new collaborations, how to interpret clinical trial data, or how to analyze software licensing sales, there are a lot of moving parts to consider. 

Let's get up to speed on three important things about this company so that you'll be on the same page as the smartest investors. Then, if you decide to buy this stock, you'll better know what you're getting into and what expectations to have.

Some biotechs aim to develop medicines for conditions that affect many people worldwide. It's no surprise why, as the more people that are afflicted, the bigger the market. Plus, common illnesses are, to state the obvious, common, which means that there's seldom much trouble when it comes to identifying and recruiting enough people for clinical trials.

Continue reading

Source Fool.com